Germany Ophthalmic Viscoelastic Devices Market

ID: MRFR/MED/54230-HCR
200 Pages
Nidhi Mandole
Last Updated: March 28, 2026
Germany Ophthalmic Viscoelastic Devices Market Research Report: Size, Share, Trend Analysis By Types (Cohesive OVDs, Dispersive OVDs), By Applications (Cataract Surgery, Glaucoma Surgery, Corneal Transplantation, Vitreoretinal Surgery) and By End Users (Ophthalmic Clinics & Phaco Centers, Hospitals, Academic & Research Institutes) - Growth Outlook & Industry Forecast 2025 To 2035
Germany Ophthalmic Viscoelastic Devices Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)4.99%
2024 Market Size$ 133.12 Million
2025 Market Size$ 202.5 Million
2035 Market Size$ 227.5 Million
Key Players
Alcon
Bausch + Lomb
Carl Zeiss AG
Hoya Corporation
Santen Pharmaceutical Co.
Ltd.
Trends
  • Technological Advancements
  • Aging Population
  • Regulatory Support
Opportunities
  • Supportive Regulatory Framework
  • Increasing Healthcare Expenditure
  • Rising Prevalence of Eye Disorders
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Application (USD Million)
      1. 4.1.1 Cataract Surgery
      2. 4.1.2 Glaucoma Surgery
      3. 4.1.3 Corneal Surgery
      4. 4.1.4 Retinal Surgery
    2. 4.2 Healthcare, BY Product Type (USD Million)
      1. 4.2.1 Sodium Hyaluronate
      2. 4.2.2 Chondroitin Sulfate
      3. 4.2.3 Hyaluronic Acid
      4. 4.2.4 Viscoelastic Mixtures
    3. 4.3 Healthcare, BY End User (USD Million)
      1. 4.3.1 Hospitals
      2. 4.3.2 Ambulatory Surgical Centers
      3. 4.3.3 Ophthalmology Clinics
    4. 4.4 Healthcare, BY Distribution Channel (USD Million)
      1. 4.4.1 Direct Sales
      2. 4.4.2 Online Sales
      3. 4.4.3 Medical Distributors
    5. 4.5 Healthcare, BY Formulation (USD Million)
      1. 4.5.1 Pre-filled Syringes
      2. 4.5.2 Vials
      3. 4.5.3 Bulk Solutions
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Alcon (CH)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Bausch + Lomb (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Carl Zeiss AG (DE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Hoya Corporation (JP)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Santen Pharmaceutical Co., Ltd. (JP)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Abbott Laboratories (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Merck KGaA (DE)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Rayner Surgical Group (GB)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Eyevance Pharmaceuticals (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 GERMANY MARKET ANALYSIS BY APPLICATION
    3. 6.3 GERMANY MARKET ANALYSIS BY PRODUCT TYPE
    4. 6.4 GERMANY MARKET ANALYSIS BY END USER
    5. 6.5 GERMANY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    6. 6.6 GERMANY MARKET ANALYSIS BY FORMULATION
    7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF HEALTHCARE
    10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
    13. 6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    14. 6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
    15. 6.15 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
    16. 6.16 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
    17. 6.17 HEALTHCARE, BY END USER, 2024 (% SHARE)
    18. 6.18 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million)
    19. 6.19 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    20. 6.20 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
    21. 6.21 HEALTHCARE, BY FORMULATION, 2024 (% SHARE)
    22. 6.22 HEALTHCARE, BY FORMULATION, 2024 TO 2035 (USD Million)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2026-2035 (USD Million)
      2. 7.2.2 BY PRODUCT TYPE, 2026-2035 (USD Million)
      3. 7.2.3 BY END USER, 2026-2035 (USD Million)
      4. 7.2.4 BY DISTRIBUTION CHANNEL, 2026-2035 (USD Million)
      5. 7.2.5 BY FORMULATION, 2026-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

Germany Ophthalmic Viscoelastic Devices Market Segmentation

Germany Ophthalmic Viscoelastic Devices Market By Application (USD Million, 2026-2035)

  • Cataract Surgery
  • Glaucoma Surgery
  • Corneal Surgery
  • Retinal Surgery

Germany Ophthalmic Viscoelastic Devices Market By Product Type (USD Million, 2026-2035)

  • Sodium Hyaluronate
  • Chondroitin Sulfate
  • Hyaluronic Acid
  • Viscoelastic Mixtures

Germany Ophthalmic Viscoelastic Devices Market By End User (USD Million, 2026-2035)

  • Hospitals
  • Ambulatory Surgical Centers
  • Ophthalmology Clinics

Germany Ophthalmic Viscoelastic Devices Market By Distribution Channel (USD Million, 2026-2035)

  • Direct Sales
  • Online Sales
  • Medical Distributors

Germany Ophthalmic Viscoelastic Devices Market By Formulation (USD Million, 2026-2035)

  • Pre-filled Syringes
  • Vials
  • Bulk Solutions

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.